{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000347.1:c.159A>T",
          "cDNA Change": {
            "transcript": "NM_000347.1",
            "ref": "A",
            "alt": "T",
            "position": "159"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation (p.A53T) associated with Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0012058"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro aggregation assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Recombinant alpha-synuclein (A53T mutant and wild-type)",
        "Description": "Experiments used recombinant alpha-synuclein proteins (A53T mutant and wild-type) in in vitro aggregation assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.159A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T variant exhibited increased aggregation propensity and enhanced toxicity in cell cultures compared to wild-type alpha-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated three times with independent protein preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein was used as a positive control for normal aggregation behavior."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No protein (buffer only) was used as a negative control for aggregation."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare aggregation levels between wild-type and mutant variants."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Aggregation levels below 20% of mutant variant levels",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation levels exceeding 50% of mutant variant levels",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell toxicity assay",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "Neuroblastoma cells (SH-SY5Y)",
        "Description": "Toxicity was assessed in SH-SY5Y cells expressing wild-type or A53T mutant alpha-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.1:c.159A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Cells expressing the A53T variant showed significantly higher toxicity (measured by cell viability < 60%) compared to wild-type (cell viability > 85%)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent cell culture experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein-expressing cells were used as a positive control for normal viability."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control for toxicity."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare toxicity between wild-type and mutant variants."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability > 80%",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 60%",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}